Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Organizational Skills Treatment for ADHD Children
Verified date | April 2013 |
Source | New York University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
This study will evaluate the effectiveness of organizational skills training in improving organizational, time management, and planning difficulties in children with attention deficit hyperactivity disorder.
Status | Completed |
Enrollment | 157 |
Est. completion date | February 2011 |
Est. primary completion date | February 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 8 Years to 11 Years |
Eligibility |
Inclusion Criteria: - Between grades 3 and 5 in school - Meets criteria for ADHD, any subtype (a formal diagnosis prior to study entry is not necessary) - Meets minimum score requirements on either Conners Parent or Conners Teacher Rating Scales - Meets minimum criteria for organizational, time management, and planning deficits, as reported by parent or teacher - Estimated IQ is greater than 85, as determined by the Wechsler Abbreviated Scale of Intelligence - Has a teacher that is willing to participate - Parents' schedule will allow attendance at study visits Exclusion Criteria: - Attends an all-day special education classroom or works with a para-professional in school - Diagnosis of pervasive developmental disorder (PDD), psychosis, bipolar disorder, or post-traumatic stress disorder (PTSD) - Current history of significant suicidality or sexual or physical abuse - Any other comorbid psychiatric diagnosis or medical condition with significant symptoms that may interfere with study participation (e.g., severe depression, obsessive-compulsive disorder [OCD], or cystic fibrosis) - Child's teacher has previously participated in this study |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Duke University | Durham | North Carolina |
United States | New York University School of Medicine | New York | New York |
Lead Sponsor | Collaborator |
---|---|
New York University School of Medicine | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Children's Organizational Skills Scale (COSS) | Measured immediatly post-treatment, Month 1 post-treatment, and Months 1 and 4 into the following school year | No | |
Primary | Academic Performance Rating Scale (APRS) | Measured immediatly post-treatment, Month 1 post-treatment, and Months 1 and 4 into the following school year | No | |
Secondary | Homework Problems Checklist | Measured immediatly post-treatment, Month 1 post-treatment, and Months 1 and 4 into the following school year | No | |
Secondary | Family Environment Scale | Measured immediatly post-treatment, Month 1 post-treatment, and Months 1 and 4 into the following school year | No | |
Secondary | Behavior Assessment System for Children | Measured immediatly post-treatment, Month 1 post-treatment, and Months 1 and 4 into the following school year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 | |
Completed |
NCT00000388 -
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
|
Phase 4 |